Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir

PURPOSE: People chronically infected with hepatitis C virus (HCV) have diminished patient-reported outcomes (PROs). This study aimed to compare the impact of elbasvir/grazoprevir (EBR/GZR) treatment versus sofosbuvir with pegylated interferon and ribavirin (SOF/PR) on changes in PROs: 1) during the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Patient Prefer Adherence
Главные авторы: Ng, Xinyi, Nwankwo, Chizoba, Arduino, Jean Marie, Corman, Shelby, Lasch, Kathryn Eilene, Lustrino, Jacqueline Mary, Patel, Sushma, Platt, Heather Loryn, Qiu, Jingjun, Sperl, Jan
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2018
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294167/
https://ncbi.nlm.nih.gov/pubmed/30587935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S172732
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы